{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:08:44Z","timestamp":1792372124802,"version":"4.4.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00277-019-03653-7","type":"journal-article","created":{"date-parts":[[2019,3,10]],"date-time":"2019-03-10T21:49:54Z","timestamp":1552254594000},"page":"1367-1381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60\u201369\u00a0years with myelodysplastic syndrome"],"prefix":"10.1007","volume":"98","author":[{"given":"Hidehiro","family":"Itonaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuteru","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Sakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuju","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Iwato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoko","family":"Takanashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,11]]},"reference":[{"issue":"19","key":"3653_CR1","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1056\/NEJMra0902908","volume":"361","author":"A Tefferi","year":"2009","unstructured":"Tefferi A, Vardiman JW (2009) Myelodysplastic syndromes. N Engl J Med 361(19):1872\u20131885","journal-title":"N Engl J Med"},{"issue":"12","key":"3653_CR2","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sol\u00e9 F et al (2012) Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 120(12):2454\u20132465","journal-title":"Blood."},{"issue":"1","key":"3653_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.leukres.2013.10.013","volume":"38","author":"J Neukirchen","year":"2014","unstructured":"Neukirchen J, Lauseker M, Blum S, Giagounidis A, L\u00fcbbert M, Martino S, Siragusa S, Schlenk RF, Platzbecker U, Hofmann WK, G\u00f6tze K, Palumbo GA, Magrin S, K\u00fcndgen A, Aul C, Hildebrandt B, Hasford J, Kobbe G, Haas R, Germing U (2014) Validation of the revised international prognostic scoring system (IPSS-R) in patients with myelodysplastic syndrome: a multicenter study. Leuk Res 38(1):57\u201364","journal-title":"Leuk Res"},{"issue":"18","key":"3653_CR4","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1016\/j.ejca.2014.09.016","volume":"50","author":"MF Spronsen van","year":"2014","unstructured":"van Spronsen MF, Ossenkoppele GJ, Holman R, van de Loosdrecht AA (2014) Improved risk stratification by the integration of the revised international prognostic scoring system with the myelodysplastic syndromes comorbidity index. Eur J Cancer 50(18):3198\u20133205","journal-title":"Eur J Cancer"},{"issue":"21","key":"3653_CR5","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1200\/JCO.2012.48.0764","volume":"31","author":"MT Voso","year":"2013","unstructured":"Voso MT, Fenu S, Latagliata R, Buccisano F, Piciocchi A, Aloe-Spiriti MA, Breccia M, Criscuolo M, Andriani A, Mancini S, Niscola P, Naso V, Nobile C, Piccioni AL, D'Andrea M, D'Addosio A, Leone G, Venditti A (2013) Revised international prognostic scoring system (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO prognostic scoring system: validation by the Gruppo Romano Mielodisplasie Italian regional database. J Clin Oncol 31(21):2671\u20132677","journal-title":"J Clin Oncol"},{"issue":"3","key":"3653_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s12185-017-2250-0","volume":"106","author":"H Kawabata","year":"2017","unstructured":"Kawabata H, Tohyama K, Matsuda A, Araseki K, Hata T, Suzuki T et al (2017) Validation of the revised international prognostic scoring system in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registry. Int J Hematol 106(3):375\u2013384","journal-title":"Int J Hematol"},{"issue":"4","key":"3653_CR7","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1182\/blood-2007-02-076307","volume":"110","author":"C Chang","year":"2007","unstructured":"Chang C, Storer BE, Scott BL, Bryant EM, Shulman HM, Flowers ME, Sandmaier BM, Witherspoon RP, Nash RA, Sanders JE, Bedalov A, Hansen JA, Clurman BE, Storb R, Appelbaum FR, Deeg HJ (2007) Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders. Blood. 110(4):1379\u20131387","journal-title":"Blood."},{"issue":"10","key":"3653_CR8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/ajh.20989","volume":"82","author":"CM Flynn","year":"2007","unstructured":"Flynn CM, Hirsch B, Defor T, Barker JN, Miller JS, Wagner JE et al (2007) Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis. Am J Hematol 82(10):867\u2013872","journal-title":"Am J Hematol"},{"issue":"2","key":"3653_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/bmt.2016.266","volume":"52","author":"M Robin","year":"2017","unstructured":"Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N (2017) Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the chronic malignancy working party of the EBMT. Bone Marrow Transplant 52(2):209\u2013215","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"3653_CR10","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1182\/blood.V99.6.1943","volume":"99","author":"H Castro-Malaspina","year":"2002","unstructured":"Castro-Malaspina H, Harris RE, Gajewski J, Ramsay N, Collins R, Dharan B, King R, Deeg HJ (2002) Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program. Blood. 99(6):1943\u20131951","journal-title":"Blood."},{"issue":"2","key":"3653_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1182\/blood-2004-01-0338","volume":"104","author":"CS Cutler","year":"2004","unstructured":"Cutler CS, Lee SJ, Greenberg P, Deeg HJ, P\u00e9rez WS, Anasetti C, Bolwell BJ, Cairo MS, Gale RP, Klein JP, Lazarus HM, Liesveld JL, McCarthy P, Milone GA, Rizzo JD, Schultz KR, Trigg ME, Keating A, Weisdorf DJ, Antin JH, Horowitz MM (2004) A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood. 104(2):579\u2013585","journal-title":"Blood."},{"issue":"3","key":"3653_CR12","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1182\/blood-2005-11-4503","volume":"108","author":"R Martino","year":"2006","unstructured":"Martino R, Iacobelli S, Brand R, Jansen T, van Biezen A, Finke J, Bacigalupo A, Beelen D, Reiffers J, Devergie A, Alessandrino E, Mufti GJ, Barge R, Sierra J, Ruutu T, Boogaerts M, Falda M, Jouet JP, Niederwieser D, de Witte T, Myelodysplastic Syndrome subcommittee of the Chronic Leukemia Working Party of the European Blood and Marrow Transplantation Group (2006) Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes. Blood. 108(3):836\u2013846","journal-title":"Blood."},{"issue":"9","key":"3653_CR13","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","volume":"130","author":"L Muffly","year":"2017","unstructured":"Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea S, Copelan E, D\u2019Souza A, Edwards J, Foran J, Freytes CO, Fung HC, Gale RP, Giralt S, Hashmi SK, Hildebrandt GC, Ho V, Jakubowski A, Lazarus H, Luskin MR, Martino R, Maziarz R, McCarthy P, Nishihori T, Olin R, Olsson RF, Pawarode A, Peres E, Rezvani AR, Rizzieri D, Savani BN, Schouten HC, Sabloff M, Seftel M, Seo S, Sorror ML, Szer J, Wirk BM, Wood WA, Artz A (2017) Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States. Blood. 130(9):1156\u20131164","journal-title":"Blood."},{"issue":"15","key":"3653_CR14","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1200\/JCO.2005.05.694","volume":"23","author":"H Wallen","year":"2005","unstructured":"Wallen H, Gooley TA, Deeg HJ, Pagel JM, Press OW, Appelbaum FR, Storb R, Gopal AK (2005) Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older. J Clin Oncol 23(15):3439\u20133446","journal-title":"J Clin Oncol"},{"issue":"11","key":"3653_CR15","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/bmt.2016.156","volume":"51","author":"M Pohlen","year":"2016","unstructured":"Pohlen M, Groth C, Sauer T, G\u00f6rlich D, Mesters R, Schliemann C, Lenz G, M\u00fcller-Tidow C, B\u00fcchner T, Berdel WE, Stelljes M (2016) Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (\u2a7e60 years). Bone Marrow Transplant 51(11):1441\u20131448","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"3653_CR16","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1200\/JCO.2009.25.4821","volume":"28","author":"BL McClune","year":"2010","unstructured":"McClune BL, Weisdorf DJ, Pedersen TL, Tunes da Silva G, Tallman MS, Sierra J et al (2010) Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. J Clin Oncol 28(11):1878\u20131887","journal-title":"J Clin Oncol"},{"issue":"17","key":"3653_CR17","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1001\/jama.2011.1558","volume":"306","author":"ML Sorror","year":"2011","unstructured":"Sorror ML, Sandmaier BM, Storer BE, Franke GN, Laport GG, Chauncey TR, Agura E, Maziarz RT, Langston A, Hari P, Pulsipher MA, Bethge W, Sahebi F, Bruno B, Maris MB, Yeager A, Petersen FB, Vindel\u00f8v L, McSweeney PA, H\u00fcbel K, Mielcarek M, Georges GE, Niederwieser D, Blume KG, Maloney DG, Storb R (2011) Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies. JAMA. 306(17):1874\u20131883","journal-title":"JAMA."},{"issue":"7","key":"3653_CR18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/bmt.2010.227","volume":"46","author":"L Castagna","year":"2011","unstructured":"Castagna L, F\u00fcrst S, Marchetti N, El Cheikh J, Faucher C, Mohty M et al (2011) Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT. Bone Marrow Transplant 46(7):1000\u20131005","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"3653_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/sj.leu.2403640","volume":"19","author":"K Nakai","year":"2005","unstructured":"Nakai K, Kanda Y, Fukuhara S, Sakamaki H, Okamoto S, Kodera Y, Tanosaki R, Takahashi S, Matsushima T, Atsuta Y, Hamajima N, Kasai M, Kato S (2005) Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome. Leukemia. 19(3):396\u2013401","journal-title":"Leukemia."},{"issue":"8","key":"3653_CR20","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.bbmt.2012.01.009","volume":"18","author":"AT Gerds","year":"2012","unstructured":"Gerds AT, Gooley TA, Estey EH, Appelbaum FR, Deeg HJ, Scott BL (2012) Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS. Biol Blood Marrow Transplant 18(8):1211\u20131218","journal-title":"Biol Blood Marrow Transplant"},{"issue":"36","key":"3653_CR21","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1200\/JCO.2012.44.3499","volume":"30","author":"G Damaj","year":"2012","unstructured":"Damaj G, Duhamel A, Robin M, Beguin Y, Michallet M, Mohty M, Vigouroux S, Bories P, Garnier A, el Cheikh J, Bulabois CE, Huynh A, Bay JO, Legrand F, Deconinck E, Fegueux N, Clement L, Dauriac C, Maillard N, Cornillon J, Ades L, Guillerm G, Schmidt-Tanguy A, Marjanovic Z, Park S, Rubio MT, Marolleau JP, Garnier F, Fenaux, Yakoub-Agha I (2012) Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie-Cellulaire and the Groupe-Francophone des My\u00e9lodysplasies. J Clin Oncol 30(36):4533\u20134540","journal-title":"J Clin Oncol"},{"issue":"7","key":"3653_CR22","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/annonc\/mdx154","volume":"28","author":"MT Voso","year":"2017","unstructured":"Voso MT, Leone G, Piciocchi A, Fianchi L, Santarone S, Candoni A, Criscuolo M, Masciulli A, Cerqui E, Molteni A, Finelli C, Parma M, Poloni A, Carella AM, Spina F, Cortelezzi A, Salvi F, Alessandrino EP, Rambaldi A, Sica S (2017) Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study. Ann Oncol 28(7):1547\u20131553","journal-title":"Ann Oncol"},{"issue":"2","key":"3653_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/bmt.2009.134","volume":"45","author":"T Field","year":"2010","unstructured":"Field T, Perkins J, Huang Y, Kharfan-Dabaja MA, Alsina M, Ayala E, Fernandez HF, Janssen W, Lancet J, Perez L, Sullivan D, List A, Anasetti C (2010) 5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 45(2):255\u2013260","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"3653_CR24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/bmt.2011.86","volume":"47","author":"DY Kim","year":"2012","unstructured":"Kim DY, Lee JH, Park YH, Lee JH, Kim SD, Choi Y, Lee SB, Lee KH, Ahn SY, Lee YS, Seol M, Kang YA, Jeon M, Jung AR, Lee YJ, Lee KH (2012) Feasibility of hypomethylating agents followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome. Bone Marrow Transplant 47(3):374\u2013379","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"3653_CR25","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","volume":"30","author":"J Schanz","year":"2012","unstructured":"Schanz J, T\u00fcchler H, Sol\u00e9 F, Mallo M, Lu\u00f1o E, Cervera J, Granada I, Hildebrandt B, Slovak ML, Ohyashiki K, Steidl C, Fonatsch C, Pfeilst\u00f6cker M, N\u00f6sslinger T, Valent P, Giagounidis A, Aul C, L\u00fcbbert M, Stauder R, Krieger O, Garcia-Manero G, Faderl S, Pierce S, le Beau MM, Bennett JM, Greenberg P, Germing U, Haase D (2012) New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol 30(8):820\u2013829","journal-title":"J Clin Oncol"},{"issue":"21","key":"3653_CR26","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1200\/JCO.2012.46.8652","volume":"31","author":"J Koreth","year":"2013","unstructured":"Koreth J, Pidala J, Perez WS, Deeg HJ, Garcia-Manero G, Malcovati L, Cazzola M, Park S, Itzykson R, Ades L, Fenaux P, Jadersten M, Hellstrom-Lindberg E, Gale RP, Beach CL, Lee SJ, Horowitz MM, Greenberg PL, Tallman MS, DiPersio JF, Bunjes D, Weisdorf DJ, Cutler C (2013) Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis. J Clin Oncol 31(21):2662\u20132670","journal-title":"J Clin Oncol"},{"issue":"3","key":"3653_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/bjh.13124","volume":"168","author":"K Aoki","year":"2015","unstructured":"Aoki K, Ishikawa T, Ishiyama K, Aoki J, Itonaga H, Fukuda T, Kakihana K, Uchida N, Ueda Y, Eto T, Mori T, Kondo T, Iwato K, Morishima Y, Tanaka J, Atsuta Y, Miyazaki Y, The Adult MyelodysplasticSyndromes Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) (2015) Allogeneic haematopoietic cell transplantation with reduced-intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study. Br J Haematol 168(3):463\u2013466","journal-title":"Br J Haematol"},{"issue":"1","key":"3653_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","volume":"103","author":"Y Atsuta","year":"2016","unstructured":"Atsuta Y (2016 Jan) Introduction of transplant registry unified management program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data). Int J Hematol 103(1):3\u201310","journal-title":"Int J Hematol"},{"issue":"1","key":"3653_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12185-015-1907-9","volume":"103","author":"J Kanda","year":"2016","unstructured":"Kanda J (2016) Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation. Int J Hematol 103(1):11\u201319","journal-title":"Int J Hematol"},{"issue":"3","key":"3653_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF03006932","volume":"86","author":"Y Atsuta","year":"2007","unstructured":"Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A, Kato K, Tabuchi K, Tsuchida M, Morishima Y, Mitamura M, Kawa K, Kato S, Nagamura T, Takanashi M, Kodera Y (2007) Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP system. Int J Hematol 86(3):269\u2013274","journal-title":"Int J Hematol"},{"issue":"2","key":"3653_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51(2):189\u2013199","journal-title":"Br J Haematol"},{"issue":"6","key":"3653_CR32","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 89(6):2079\u20132088","journal-title":"Blood."},{"issue":"12","key":"3653_CR33","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3324\/haematol.2016.149427","volume":"101","author":"Y Inamoto","year":"2016","unstructured":"Inamoto Y, Kimura F, Kanda J, Sugita J, Ikegame K, Nakasone H, Nannya Y, Uchida N, Fukuda T, Yoshioka K, Ozawa Y, Kawano I, Atsuta Y, Kato K, Ichinohe T, Inoue M, Teshima T, on behalf of JSHCT GVHD Working Group (2016) Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups. Haematologica. 101(12):1592\u20131602","journal-title":"Haematologica."},{"key":"3653_CR34","doi-asserted-by":"publisher","unstructured":"Itonaga H, Ishiyama K, Aoki K, Aoki J, Ishikawa T, Ohashi K et al (2019) Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. \n                    https:\/\/doi.org\/10.1038\/s41409-019-0469-5","DOI":"10.1038\/s41409-019-0469-5"},{"issue":"3","key":"3653_CR35","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/ajh.24270","volume":"91","author":"J Aoki","year":"2016","unstructured":"Aoki J, Kanamori H, Tanaka M, Yamasaki S, Fukuda T, Ogawa H, Iwato K, Ohashi K, Okumura H, Onizuka M, Maesako Y, Teshima T, Kobayashi N, Morishima Y, Hirokawa M, Atsuta Y, Yano S, Takami A (2016) Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemia. Am J Hematol 91(3):302\u2013307","journal-title":"Am J Hematol"},{"issue":"4","key":"3653_CR36","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.bbmt.2017.11.016","volume":"24","author":"H Itonaga","year":"2018","unstructured":"Itonaga H, Aoki K, Aoki J, Ishikawa T, Ishiyama K, Uchida N, Sakura T, Ohashi K, Kurokawa M, Ozawa Y, Matsuoka KI, Nakamura Y, Kimura F, Iwato K, Nawa Y, Hirokawa M, Kato K, Ichinohe T, Atsuta Y, Miyazaki Y (2018) Prognostic impact of donor source on allogeneic hematopoietic stem cell transplantation outcomes in adults with chronic myelomonocytic leukemia: a nationwide retrospective analysis in Japan. Biol Blood Marrow Transplant 24(4):840\u2013848","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"3653_CR37","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B (2009) Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 15(3):367\u2013369","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"3653_CR38","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M (2009) Defining the intensity of conditioning regimens: working definitions. Biol Bone Marrow Transplant 15(12):1628\u20131633","journal-title":"Biol Bone Marrow Transplant"},{"issue":"6","key":"3653_CR39","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED (1995) 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 15(6):825\u2013828","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"3653_CR40","first-page":"250","volume":"28","author":"KM Sullivan","year":"1991","unstructured":"Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, Erickson K, Flowers M, Hansen J, Loughran T (1991) Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 28(3):250\u2013259","journal-title":"Semin Hematol"},{"issue":"11","key":"3653_CR41","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1182\/blood-2013-04-496778","volume":"122","author":"W Saber","year":"2013","unstructured":"Saber W, Cutler CS, Nakamura R, Zhang MJ, Atallah E, Rizzo JD, Maziarz RT, Cortes J, Kalaycio ME, Horowitz MM (2013) Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). Blood. 122(11):1974\u20131982","journal-title":"Blood."},{"issue":"8","key":"3653_CR42","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","volume":"125","author":"SG Holtan","year":"2015","unstructured":"Holtan SG, DeFor TE, Lazaryan A, Bejanyan N, Arora M, Brunstein CG et al (2015) Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. Blood. 125(8):1333\u20131338","journal-title":"Blood."},{"issue":"8","key":"3653_CR43","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.bbmt.2016.04.006","volume":"22","author":"M Solh","year":"2016","unstructured":"Solh M, Zhang X, Connor K, Brown S, Solomon SR, Morris LE, Holland HK, Bashey A (2016) Factors predicting graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation: multivariable analysis from a single center. Biol Blood Marrow Transplant 22(8):1403\u20131409","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"3653_CR44","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18(6):695\u2013706","journal-title":"Stat Med"},{"issue":"446","key":"3653_CR45","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ (1999) A proportional hazards model for subdistribution of a competing risk. J Am Stat Assoc 94(446):496\u2013509","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"3653_CR46","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 48(3):452\u2013458","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"3653_CR47","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.bbmt.2014.01.025","volume":"20","author":"D Chihara","year":"2014","unstructured":"Chihara D, Izutsu K, Kondo E, Sakai R, Mizuta S, Yokoyama K, Kaneko H, Kato K, Hasegawa Y, Chou T, Sugahara H, Henzan H, Sakamaki H, Suzuki R, Suzumiya J (2014) High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed\/refractory diffuse large B cell lymphoma: a nationwide retrospective study. Biol Blood Marrow Transplant 20(5):684\u2013689","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"3653_CR48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/bjh.13608","volume":"171","author":"HW Auner","year":"2015","unstructured":"Auner HW, Garderet L, Kr\u00f6ger N et al (2015) Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma. Br J Haematol 171(4):453\u2013462","journal-title":"Br J Haematol"},{"issue":"10","key":"3653_CR49","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1111\/j.1600-6143.2012.04245.x","volume":"12","author":"M Abecassis","year":"2012","unstructured":"Abecassis M, Bridges ND, Clancy CJ, Dew MA, Eldadah B, Englesbe MJ, Flessner MF, Frank JC, Friedewald J, Gill J, Gries C, Halter JB, Hartmann EL, Hazzard WR, Horne FM, Hosenpud J, Jacobson P, Kasiske BL, Lake J, Loomba R, Malani PN, Moore TM, Murray A, Nguyen MH, Powe NR, Reese PP, Reynolds H, Samaniego MD, Schmader KE, Segev DL, Shah AS, Singer LG, Sosa JA, Stewart ZA, Tan JC, Williams WW, Zaas DW, High KP (2012) Solid-organ transplantation in older adults: current status and future research. Am J Transplant 12(10):2608\u20132622","journal-title":"Am J Transplant"},{"issue":"3","key":"3653_CR50","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/leu.2010.285","volume":"25","author":"AB Madureira","year":"2011","unstructured":"Madureira AB, Eapen M, Locatelli F, Teira P, Zhang MJ, Davies SM, Picardi A, Woolfrey A, Chan KW, Soci\u00e9 G, Vora A, Bertrand Y, Sales-Bonfim CM, Gluckman E, Niemeyer C, Rocha V, Eurocord-European Blood and Marrow Transplant Group, Center of International Blood and Marrow Transplant Registry, European Working Group on childhood MDS (2011) Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation. Leukemia. 25(3):449\u2013454","journal-title":"Leukemia."},{"issue":"1","key":"3653_CR51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/leu.2010.219","volume":"25","author":"M Robin","year":"2011","unstructured":"Robin M, Sanz GF, Ionescu I, Rio B, Sirvent A, Renaud M, Carreras E, Milpied N, Mohty M, Beguin Y, Bordigoni P, de Witte T, Picardi A, Purtill D, Gluckman E, Kroger N, Rocha V (2011) Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT. Leukemia. 25(1):75\u201381","journal-title":"Leukemia."},{"issue":"4","key":"3653_CR52","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1182\/blood-2013-02-453175","volume":"122","author":"KK Ballen","year":"2013","unstructured":"Ballen KK, Gluckman E, Broxmeyer HE (2013) Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 122(4):491\u2013498","journal-title":"Blood."},{"issue":"4","key":"3653_CR53","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bbmt.2008.12.508","volume":"15","author":"M Yazaki","year":"2009","unstructured":"Yazaki M, Atsuta Y, Kato K, Kato S, Taniguchi S, Takahashi S, Ogawa H, Kouzai Y, Kobayashi T, Inoue M, Kobayashi R, Nagamura-Inoue T, Azuma H, Takanashi M, Kai S, Nakabayashi M, Saito H, Japan Cord Blood Bank Network (2009) Incidence and risk factors of early bacterial infections after unrelated cord blood transplantation. Biol Blood Marrow Transplant 15(4):439\u2013446","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"3653_CR54","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/bmt.2015.76","volume":"50","author":"M Ogata","year":"2015","unstructured":"Ogata M, Fukuda T, Teshima T (2015) Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know. Bone Marrow Transplant 50(8):1030\u20131036","journal-title":"Bone Marrow Transplant"},{"issue":"1\u20133","key":"3653_CR55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12026-009-8139-0","volume":"47","author":"L Luznik","year":"2010","unstructured":"Luznik L, Fuchs EJ (2010) High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation. Immunol Res 47(1\u20133):65\u201377","journal-title":"Immunol Res"},{"issue":"1","key":"3653_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbmt.2012.08.014","volume":"19","author":"AM Raiola","year":"2013","unstructured":"Raiola AM, Dominietto A, Ghiso A, Di Grazia C, Lamparelli T, Gualandi F et al (2013) Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning. Biol Blood Marrow Transplant 19(1):117\u2013122","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"3653_CR57","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/ajh.23392","volume":"88","author":"Y Kanda","year":"2013","unstructured":"Kanda Y, Oshima K, Kako S, Fukuda T, Uchida N, Miyamura K, Kondo Y, Nakao S, Nagafuji K, Miyamoto T, Kurokawa M, Okoshi Y, Chiba S, Ohashi Y, Takaue Y, Taniguchi S (2013) In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation. Am J Hematol 88(4):294\u2013300","journal-title":"Am J Hematol"},{"issue":"6","key":"3653_CR58","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1200\/JCO.2006.07.0953","volume":"25","author":"DA Rizzieri","year":"2007","unstructured":"Rizzieri DA, Koh LP, Long GD, Gasparetto C, Sullivan KM, Horwitz M, Chute J, Smith C, Gong JZ, Lagoo A, Niedzwiecki D, Dowell JM, Waters-Pick B, Liu CX, Marshall D, Vredenburgh JJ, Gockerman J, Decastro C, Moore J, Chao NJ (2007) Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. J Clin Oncol 25(6):690\u2013697","journal-title":"J Clin Oncol"},{"issue":"2","key":"3653_CR59","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/leu.2012.203","volume":"27","author":"J Kanda","year":"2013","unstructured":"Kanda J, Ichinohe T, Kato S, Uchida N, Terakura S, Fukuda T et al (2013) Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction. Leukemia. 27(2):286\u2013294","journal-title":"Leukemia."},{"issue":"9","key":"3653_CR60","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1182\/blood-2011-02-339838","volume":"118","author":"KH Lee","year":"2011","unstructured":"Lee KH, Lee JH, Lee JH, Kim DY, Seol M, Lee YS, Kang YA, Jeon M, Hwang HJ, Jung AR, Kim SH, Yun SC, Shin HJ (2011) Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome. Blood. 118(9):2609\u20132617","journal-title":"Blood."},{"issue":"1","key":"3653_CR61","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbmt.2016.09.027","volume":"23","author":"S Heidenreich","year":"2017","unstructured":"Heidenreich S, Ziagkos D, de Wreede LC, van Biezen A, Finke J, Platzbecker U, Niederwieser D, Einsele H, Bethge W, Schleuning M, Beelen DW, Tischer J, Nagler A, Glass B, Maertens J, Y\u00e1\u00f1ez L, Beguin Y, Sill H, Scheid C, Stelljes M, Ganser A, Zach\u00e9e P, Selleslag D, de Witte T, Robin M, Kr\u00f6ger N (2017) Allogeneic stem cell transplantation for patients age \u2265 70 years with myelodysplastic syndrome: a retrospective study of the MDS subcommittee of the chronic malignancies working party of the EBMT. Biol Blood Marrow Transplant 23(1):44\u201352","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"3653_CR62","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.bbmt.2017.03.020","volume":"23","author":"BM Getta","year":"2017","unstructured":"Getta BM, Kishtagari A, Hilden P, Tallman MS, Maloy M, Gonzales P, Castro-Malaspina H, Perales MA, Giralt S, Tamari R, Klimek V (2017) Allogeneic hematopoietic stem cell transplantation is underutilized in older patients with myelodysplastic syndromes. Biol Blood Marrow Transplant 23(7):1078\u20131086","journal-title":"Biol Blood Marrow Transplant"},{"issue":"17","key":"3653_CR63","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1182\/blood-2016-12-754796","volume":"129","author":"T Yoshizato","year":"2017","unstructured":"Yoshizato T, Nannya Y, Atsuta Y, Shiozawa Y, Iijima-Yamashita Y, Yoshida K, Shiraishi Y, Suzuki H, Nagata Y, Sato Y, Kakiuchi N, Matsuo K, Onizuka M, Kataoka K, Chiba K, Tanaka H, Ueno H, Nakagawa MM, Przychodzen B, Haferlach C, Kern W, Aoki K, Itonaga H, Kanda Y, Sekeres MA, Maciejewski JP, Haferlach T, Miyazaki Y, Horibe K, Sanada M, Miyano S, Makishima H, Ogawa S (2017) Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. Blood. 129(17):2347\u20132358","journal-title":"Blood."},{"issue":"30","key":"3653_CR64","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1200\/JCO.2016.67.3616","volume":"34","author":"MG Della Porta","year":"2016","unstructured":"Della Porta MG, Gall\u00ec A, Bacigalupo A, Zibellini S, Bernardi M, Rizzo E, Allione B, van Lint MT, Pioltelli P, Marenco P, Bosi A, Voso MT, Sica S, Cuzzola M, Angelucci E, Rossi M, Ubezio M, Malovini A, Limongelli I, Ferretti VV, Spinelli O, Tresoldi C, Pozzi S, Luchetti S, Pezzetti L, Catrical\u00e0 S, Milanesi C, Riva A, Bruno B, Ciceri F, Bonifazi F, Bellazzi R, Papaemmanuil E, Santoro A, Alessandrino EP, Rambaldi A, Cazzola M (2016) Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation. J Clin Oncol 34(30):3627\u20133637","journal-title":"J Clin Oncol"},{"issue":"25","key":"3653_CR65","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1200\/JCO.2013.52.3381","volume":"32","author":"R Bejar","year":"2014","unstructured":"Bejar R, Stevenson KE, Caughey B, Lindsley RC, Mar BG, Stojanov P, Getz G, Steensma DP, Ritz J, Soiffer R, Antin JH, Alyea E, Armand P, Ho V, Koreth J, Neuberg D, Cutler CS, Ebert BL (2014) Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem cell transplantation. J Clin Oncol 32(25):2691\u20132698","journal-title":"J Clin Oncol"},{"issue":"10","key":"3653_CR66","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1182\/blood-2006-10-054924","volume":"109","author":"P Armand","year":"2007","unstructured":"Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP, Soiffer RJ, Antin JH (2007) Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood. 109(10):4586\u20134588","journal-title":"Blood."},{"key":"3653_CR67","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.exphem.2018.05.006","volume":"65","author":"K Laribi","year":"2018","unstructured":"Laribi K, Bolle D, Alani M, Ghnaya H, Le Bourdelles S, Besan\u00e7on A et al (2018) Prognostic impact of elevated pretreatment serum ferritin in patients with high-risk MDS treated with azacitidine. Exp Hematol 65:34\u201337","journal-title":"Exp Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03653-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T20:09:43Z","timestamp":1583784583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03653-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,11]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["3653"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03653-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,11]]},"assertion":[{"value":"10 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}